PPARA and Alzheimer disease: In relation to the diseases that are the object of this study, the Alzheimer's and Parkinson's disease pathways were both represented, as were the complement, PPAR, and terpenoid (cholesterol synthesis) pathways relevant to Alzheimer's disease [72], and the ubiquitin pathway relevant to Parkinson's disease and other degenerative disorders [73].